Use of cabergoline for the treatment of eye diseases caused by elevated levels of vascular endothelial growth factor

• 收藏
• 分享

专利权人:

Oseka; Maciej

发明人:

Oseka, Maciej

申请号：

DK16831636

公开号：

DK3386509T3

申请日:

2016.12.09

申请国别(地区):

DK

年份:

2019

代理人:

摘要：

The present invention relates to a use of type-2 dopaminergic receptor agonists in treatment of eye diseases caused by an elevated level of vascular endothelial growth factor (VEGF), particularly in treatment or prevention of diseases of an eye retina resulting from an increase in permeability of blood vessels and their angiogenesis using cabergoline, a dopaminergic D2 receptor agonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/